// App-Quantinova.ai

334 2014 HTN : Selective Pharmacological Kinin Receptor Activation Restores Postischemic Neovascularisation And Hindlimb Perfusion In Diabetic Mice

Researchers

Presenter

  • Louis Potier

Principal Investigators

  • Catherine Chollet

  • Fernand Gobeil

  • Ronan Roussel

  • Nadine Bouby

  • Francois Alhenc-Gelas

  • Ludovic Waeckel

Medical Centers

  • Universite de Sherbrooke, Sherbrooke, QC, Canada

  • INSERM, Paris, France

Locations

  • France

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Angiology

Disease

  • Acute limb ischemia

Biomarkers

  • Cluster of Differentiation 34

  • Cluster of differentiation 45

  • Kinase Insert Domain Receptor

  • Vascular endothelial growth factor A

Drug/Treatment

  • Streptozotocin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved